| Literature DB >> 34326012 |
Hongfei Jiang1, Qian Lin1, Leina Ma1, Shudi Luo2, Xiaoming Jiang2, Jing Fang3, Zhimin Lu4.
Abstract
Fructose metabolism and fructose kinase KHK-C/A are key factors in the development of lipid oversynthesis-promoted metabolic disorders and cancer. Here, we summarize and discuss the current knowledge about the specific features of fructose metabolism and the distinct roles of KHK-C and KHK-A in metabolic liver diseases and their relevant metabolic disorders and cancer, and we highlight the specific protein kinase activity of KHK-A in tumor development. In addition, different approaches that have been used to inhibit KHK and the exploration of KHK inhibitors in clinical treatment are introduced.Entities:
Keywords: Cancer; Fructose; Glucose; KHK-A; KHK–C; Metabolic disorders; NAFLD; NASH
Mesh:
Substances:
Year: 2021 PMID: 34326012 DOI: 10.1016/j.jgg.2021.06.006
Source DB: PubMed Journal: J Genet Genomics ISSN: 1673-8527 Impact factor: 4.275